Published in Nature on April 29, 1985
Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci U S A (1992) 6.61
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 3.99
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol (2009) 3.05
A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 2.23
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A (1989) 2.15
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc Natl Acad Sci U S A (1987) 1.61
The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res (1988) 1.60
The immunogenicity of chimeric antibodies. J Exp Med (1989) 1.25
Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med (1986) 1.21
Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library. Proc Natl Acad Sci U S A (1990) 1.20
Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies. MAbs (2009) 1.20
Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A. Proc Natl Acad Sci U S A (1987) 1.15
A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc Natl Acad Sci U S A (1989) 1.08
The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact (2003) 1.07
Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material. Clin Exp Immunol (1992) 1.00
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunol Immunother (2008) 0.99
Antibody engineering to develop new antirheumatic therapies. Arthritis Res Ther (2009) 0.97
Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis. Proc Natl Acad Sci U S A (1993) 0.96
The human IgE repertoire. Int Arch Allergy Immunol (2013) 0.94
Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions. J Exp Med (1996) 0.93
Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines. Viruses (2015) 0.91
Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL) Clin Exp Immunol (1991) 0.88
Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology (2001) 0.88
Conformational correction mechanisms aiding antigen recognition by a humanized antibody. J Exp Med (1998) 0.86
Antibodies generated from human immunoglobulin miniloci in transgenic mice. Nucleic Acids Res (1994) 0.84
One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge. Proc Natl Acad Sci U S A (1994) 0.83
Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis. Br J Pharmacol (2011) 0.83
Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting. Proc Natl Acad Sci U S A (1990) 0.81
Bispecific antibody: a tool for diagnosis and treatment of disease. Clin Exp Immunol (1990) 0.81
Chimeric anti-angiogenin antibody cAb 26-2F inhibits the formation of human breast cancer xenografts in athymic mice. Proc Natl Acad Sci U S A (1998) 0.81
Adapting antibodies for clinical use. BMJ (1992) 0.80
Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulins. Mol Pathol (2000) 0.79
The production and characterisation of a chimaeric human IgE antibody, recognising the major mite allergen Der p 1, and its chimaeric human IgG1 anti-idiotype. Mol Pathol (2002) 0.79
Production of heavy-chain class-switch variants of human monoclonal antibody by recombinant DNA technology. Clin Exp Immunol (1988) 0.79
High affinity targeting of CD23 inhibits IgE synthesis in human B cells. Immun Inflamm Dis (2015) 0.78
A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discovery. MAbs (2011) 0.78
Mapping of the high affinity Fc epsilon receptor binding site to the third constant region domain of IgE. EMBO J (1991) 0.77
Advances in the applications of monoclonal antibodies in clinical oncology. London, 6-8 May 1987. Abstracts. Br J Cancer (1987) 0.77
Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency. MAbs (2014) 0.77
High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies. Clin Exp Immunol (1999) 0.76
Selection of complementary single-variable domains for building monoclonal antibodies to native proteins. Nucleic Acids Res (2009) 0.76
Monoclonal antibodies. Can Fam Physician (1987) 0.75
Unreliable measurement of basophil maximum leukotriene release with the Bühlmann CAST 2000 enzyme-linked immunosorbent assay kit. Clin Vaccine Immunol (2006) 0.75
Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI. J Vis Exp (2014) 0.75
Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction. BMC Biotechnol (2015) 0.75
A humanized anti-DLL4 antibody promotes dysfunctional angiogenesis and inhibits breast tumor growth. Sci Rep (2016) 0.75
Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations. J Mol Recognit (2016) 0.75
Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins. Biomedicines (2017) 0.75
Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design. Oncotarget (2017) 0.75
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J (1997) 6.36
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature (1984) 4.24
Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (1986) 4.19
Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes. Nature (1982) 3.82
Structure and multiplicity of genes for the human immunoglobulin heavy chain variable region. Proc Natl Acad Sci U S A (1980) 3.82
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene (2008) 3.79
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell (1996) 3.60
Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (1984) 3.48
Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups. Cell (1986) 3.41
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol (1992) 3.41
B cells acquire antigen from target cells after synapse formation. Nature (2001) 3.31
Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity (1998) 3.27
Regulated cleavage of a contact-mediated axon repellent. Science (2000) 3.24
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
Human immunoglobulin variable region genes--DNA sequences of two V kappa genes and a pseudogene. Nature (1980) 3.14
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A (1991) 3.12
Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. Nucleic Acids Res (1981) 3.11
Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature (2001) 3.09
Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization. Proc Natl Acad Sci U S A (1982) 3.07
Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell (1994) 3.06
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types. Nature (1985) 2.92
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene. Nature (1983) 2.88
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map. Cell (1995) 2.82
The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J (1988) 2.81
TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity (1998) 2.76
Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology (1991) 2.75
The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci U S A (1998) 2.64
Mechanisms of divergence and convergence of the human immunoglobulin alpha 1 and alpha 2 constant region gene sequences. Cell (1984) 2.59
Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J (1999) 2.58
Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA. Nature (1986) 2.58
Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet (1982) 2.55
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J (1985) 2.53
A rapid procedure for colony screening using nylon filters. Nucleic Acids Res (1989) 2.51
The role of gene deletion in the immunoglobulin heavy chain switch. Nature (1980) 2.48
The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J (1989) 2.48
Human V kappa immunoglobulin gene number: implications for the origin of antibody diversity. Cell (1981) 2.47
Bacterial cloning of plasmids carrying copies of rabbit globin messenger RNA. Nature (1976) 2.45
Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res (1997) 2.44
New subgroups in the human T cell rearranging V gamma gene locus. EMBO J (1987) 2.42
Colorectal cancer pathology reporting: a regional audit. J Clin Pathol (1997) 2.41
An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing. Nature (1980) 2.41
Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg (2003) 2.40
The LIM domain: a new structural motif found in zinc-finger-like proteins. Trends Genet (1994) 2.39
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J (1994) 2.32
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron (2000) 2.30
Apoptosis: molecular regulation of cell death. Eur J Biochem (1996) 2.29
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature (1988) 2.28
Human immunoglobulin heavy chain A2 gene allotype determination by restriction fragment length polymorphism. Nucleic Acids Res (1984) 2.27
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter. Mol Cell Biol (1987) 2.17
Evolution of immunoglobulin V genes: evidence indicating that recently duplicated human V kappa sequences have diverged by gene conversion. Cell (1983) 2.15
Granulomatous inflammation--a review. J Clin Pathol (1983) 2.15
Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes. Nature (1985) 2.15
Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol (1981) 2.11
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J (1996) 2.11
Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability. EMBO J (1985) 2.10
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A (1994) 2.09
Somatic hypermutation. Curr Opin Immunol (1995) 2.08
Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases. Cell (1994) 2.07
A human chromosome 8 region with abnormalities in B cell, HTLV-I+ T cell and c-myc amplified tumours. EMBO J (1987) 2.07
Squamous carcinoma of the colorectum and its genesis. J Pathol (1979) 2.07
Complex rearrangements within the human J delta-C delta/J alpha-C alpha locus and aberrant recombination between J alpha segments. EMBO J (1988) 2.05
Topographic guidance labels in a sensory projection to the forebrain. Neuron (1998) 2.03
Evidence for noncontiguous variable and constant region genes in both germ line and myeloma DNA. Cell (1978) 1.99
The B-cell antigen receptor of the five immunoglobulin classes. Nature (1991) 1.97
Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc Natl Acad Sci U S A (1995) 1.96
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94
Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today (1993) 1.93
The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer (2002) 1.88
The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J (1999) 1.88
Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell (1985) 1.87
Immunoglobulin heavy chain genes in humans are located on chromosome. Ann Hum Genet (1981) 1.85
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J (1991) 1.83
Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J (1987) 1.82
Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology (1999) 1.82
A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet (1994) 1.81
Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J (1989) 1.81
Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology (1997) 1.80
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80